Epclusa is an antiviral medicine used to treat patients from 3 years of age with chronic (long-term) hepatitis C, an infectious disease that affects the liver, caused by the hepatitis C virus. Hepatitis C virus occurs in several varieties (genotypes), and Epclusa can be used to treat hepatitis C caused by all genotypes of the virus. Epclusa contains the active substances sofosbuvir and velpatasvir.
Therapeutic Indication
### Therapeutic indication Epclusa is indicated for the treatment of chronic hepatitis C virus (HCV) infection in patients 3 years of age and older (see sections 4.2, 4.4 and 5.1).
Therapeutic Area (MeSH)
N/AATC Code
J05A
ATC Item
直接作用的抗病毒药
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
N/AINN / Common Names
N/AEMA Name
Epclusa
Medicine Name
Epclusa
Aliases
N/ANo risk management plan link.
